FP
Flagship Pioneering Portfolio holdings
AUM
$268M
This Quarter Return
-16.25%
1 Year Return
-54.4%
3 Year Return
-51.2%
5 Year Return
+66.7%
10 Year Return
–
AUM
$2.31B
AUM Growth
+$2.31B
(-13%)
Cap. Flow
+$176M
Cap. Flow
% of AUM
7.64%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
2
Increased
1
Reduced
1
Closed
–
Top Buys
| 1 |
AXLA
Axcella Health Inc. Common Stock
AXLA
|
$81.4M |
| 2 |
Transmedics
TMDX
|
$73.4M |
| 3 |
Seres Therapeutics
MCRB
|
$28.6M |
Top Sells
| 1 |
Quanterix
QTRX
|
$6.93M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Moderna
MRNA
$9.37B
| $861M | 37.27% | 58,807,379 | – | – |
|
|
RUBY
2
DELISTED
Rubius Therapeutics, Inc
RUBY
| $602M | 26.07% | 38,296,526 | – | – |
|
|
KLDO
3
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $201M | 8.72% | 17,360,710 | – | – |
|
4
Denali Therapeutics
DNLI
$2.23B
| $166M | 7.19% | 8,005,747 | – | – |
|
|
EVLO
5
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $164M | 7.09% | 18,233,403 | – | – |
|
|
AXLA
6
DELISTED
Axcella Health Inc. Common Stock
AXLA
| $81.4M | 3.53% | +8,748,414 | New | +$81.4M |
|
|
7
Transmedics
TMDX
$3.92B
| $73.4M | 3.18% | +2,530,275 | New | +$73.4M |
|
|
8
Seres Therapeutics
MCRB
$166M
| $69.5M | 3.01% | 21,571,764 +8,888,888 | +70% | +$28.6M |
|
|
9
Quanterix
QTRX
$211M
| $61.7M | 2.67% | 1,825,412 -205,083 | -10% | -$6.93M |
|
|
SYRS
10
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $29.7M | 1.28% | 3,204,437 | – | – |
|